Veronica Hackethal MD

A new study sheds light on the economic and clinical costs associated with "maintaining a failing T2DM treatment regimen."

Intensify treatment and minimize weight gain/hypoglycemia? It's possible, say results of the first study to compare a GLP-1 agonist with titrated lispro on a background of optimized basal insulin.

This is the first in a series of studies to determine whether the longer, flatter action profile of U300 insulin glargine (vs U100 glargine) will result in less hypoglycemia, and especially nocturnal events.

A recent study identifies a sweet spot for use of premixed biphasic insulin 50/50 in routine clinical practice.

Faulty brain satiety centers and impaired gut hormone function are risk factors for weight gain in patients with type 2 diabetes. A recent study suggests one simple antidote: Slow down.

Some researchers now suspect that type 2 diabetes may itself be an independent risk factor for osteoarthritis and have proposed a "diabetes-induced phenotype."

Inpatient hyperglycemia found on admission blood tests can be explained by medications, stress reaction, or, “Other.” When is “other” a red flag for diabetes? A new online tool from Scotland may help answer that.

If the BCGS model is accurate, brain and periphery communicate continuously about glucose homeostasis and a change in the brain can alter insulin sensitivity in the periphery. Read this review, and you'll be up-to-date.

The debate continues around the effect of nonsurgical periodontal therapy on HbA1C levels in persons with type 2 diabetes and chronic periodontitis. Now, a critical review of the study that triggered the controversy.

Half of patients with pancreatic cancer have DM at diagnosis; long-standing type 1 or type 2 DM may increase the risk of pancreatic cancer by 40% to 100%. Which comes first? Consider the studies, here.

Women receive less aggressive screening for and care of cardiovascular risk factors than men. The sex disparity places women with diabetes at particular risk for CVD morbidity.

Women tend to be diagnosed with cardiovascular disease later in life than men. But a diagnosis of type 2 diabetes in a woman appears to nullify a gender-protective effect.

Diagnoses of type 2 diabetes among US youth increased three-fold between 2001 and 2009. These children will enter their 20s with adult complications. Here, how to help stem the tide.

The observed insulin responses to sustained hypoxia at high altitudes has prompted deeper inquiry into the role of oxidative stress in the pathophysiology of type 2 diabetes.

While the evidence is very preliminary, it is thought that SGLT2 inhibitors may suppress glomerular hyperfiltration, hypoglycemia-related tubular growth, kidney hypertrophy, and other harbingers of diabetic nephropathy.